New arthritis drug shows promise in early testing
NCT ID NCT06567470
Summary
This study is testing whether an experimental drug called CIT-013 can reduce symptoms in adults with moderately active rheumatoid arthritis. Participants will receive injections every other week for 6 weeks, with some receiving the drug and others receiving a placebo for comparison. Researchers will measure changes in joint swelling, pain, and inflammation to determine if the treatment is effective and safe.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RHEUMATOID ARTHRITIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
BE-02
NOT_YET_RECRUITINGAntwerp, Belgium
Contact
-
DE-01
NOT_YET_RECRUITINGMünchen, Germany
Contact
-
DE-02
RECRUITINGMünchen, Germany
Contact
-
DE-03
RECRUITINGRatingen, Germany
Contact
-
DE-04
RECRUITINGBamberg, Germany
Contact
-
DE-05
RECRUITINGBerlin, Germany
Contact
-
ES-01
NOT_YET_RECRUITINGSantander, Spain
Contact
-
ES-02
RECRUITINGA Coruña, Spain
Contact
-
ES-03
RECRUITINGSantiago de Compostela, Spain
Contact
-
ES-04
RECRUITINGBarcelona, Spain
Contact
-
ES-05
NOT_YET_RECRUITINGBarcelona, Spain
Contact
-
ES-06
RECRUITINGMadrid, Spain
Contact
-
NL-01
RECRUITINGRotterdam, Netherlands
Contact
-
NL-02
RECRUITINGAmsterdam, Netherlands
Contact
-
NL-03
NOT_YET_RECRUITINGNijmegen, Netherlands
Contact
-
NL-04
WITHDRAWNLeiden, Netherlands
-
NL-05
RECRUITINGLeeuwarden, Netherlands
Contact
-
PL-01
RECRUITINGBialystok, Poland
Contact
-
PL-02
RECRUITINGPoznan, Poland
Contact
-
PL-03
RECRUITINGLublin, Poland
Contact
-
PL-04
RECRUITINGWarsaw, Poland
Contact
-
PL-05
RECRUITINGTorun, Poland
Contact
-
PL-07
RECRUITINGKrakow, Poland
Contact
-
Site BE-01
RECRUITINGLeuven, Belgium
Contact
Conditions
Explore the condition pages connected to this study.